<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteSelf Assembly &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/discipline/self-assembly/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies</title>
				<link>https://wyss.stage.a17.io/news/attivare-licenses-wyss-institutes-immune-modulating-biomaterial-technology-to-advance-immunotherapies/</link>
        <pubDate>Wed, 02 Oct 2024 13:20:13 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Massachusetts General Hospital]]></category>
		<category><![CDATA[Technology Translation]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41088</guid>
                            <description>The startup is leveraging the biomaterial-based technology to develop novel therapies able to program anti-cancer immunity and prevent infectious diseases</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Attivare Therapeutics Inc. announced that Attivare has licensed a portfolio of immune&#x2d;modulating biomaterial technologies from Harvard University that was created at the Wyss Institute, John A. Paulson School of Engineering and Applied Sciences (SEAS)&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/attivare-licenses-wyss-institutes-immune-modulating-biomaterial-technology-to-advance-immunotherapies/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/attivare-licenses-wyss-institutes-immune-modulating-biomaterial-technology-to-advance-immunotherapies/</link>
          <title> The OMNIVAX infection vaccine approach incorporates pathogen-derived antigens into an injectable biomaterial scaffold which presents them together with immune cell attracting and activating factors to dendritic immune cells that then go on to orchestrate multi-faceted immune responses against the pathogen in nearby lymph nodes. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2020/05/20143742/MPS-Scaffold-SEM-001-e1590000157764.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=b22cd283948c2a998b8ada8474c9e03f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Crisscross Nanoseed Detection: Nanotechnology-Powered Infectious Disease Diagnostics</title>
				<link>https://wyss.stage.a17.io/technology/crisscross-nanoseed-detection-nanotechnology-powered-infectious-disease-diagnostics/</link>
        <pubDate>Wed, 01 May 2024 09:34:25 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Pathogen]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=29591</guid>
                                                <content:encoded><![CDATA[<p>Speed, accuracy, and affordability are of the essence in the detection of established and newly emerging pathogens to provide timely care, mitigate transmission, and help lower the financial burden on healthcare systems. Among them, those causing sexually transmitted diseases (STIs), including HIV/AIDS and hepatitis C, cause a major global burden on health care systems. In the U.S. alone&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/crisscross-nanoseed-detection-nanotechnology-powered-infectious-disease-diagnostics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/crisscross-nanoseed-detection-nanotechnology-powered-infectious-disease-diagnostics/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2021/08/17153819/Crisscross_Featured-image-002.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=e3f54f5341d8898e9d8903bf29d81763"/></url>
				</image>
        			</item>

		
			<item>
				<title>DNA Nanostructures for Drug Delivery</title>
				<link>https://wyss.stage.a17.io/technology/dna-nanostructures-for-drug-delivery/</link>
        <pubDate>Mon, 29 Apr 2024 05:58:48 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[DNA Bricks]]></category>
		<category><![CDATA[Origami]]></category>
		<category><![CDATA[Peng Yin]]></category>
		<category><![CDATA[Programmable Nanomaterials]]></category>
		<category><![CDATA[Self-Assembly]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.prod.a17.io/?post_type=technology&#038;p=5342</guid>
                                                <content:encoded><![CDATA[<p>Researchers at the Wyss Institute have developed two methods for building arbitrarily shaped nanostructures using DNA, with a focus on translating the technology towards nanofabrication and drug delivery applications. One proprietary nanofabrication technique, called &ldquo;DNA&#x2d;brick self&#x2d;assembly,&rdquo; uses short, synthetic strands of DNA that work like interlocking Lego&reg; bricks. It capitalizes on the&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/dna-nanostructures-for-drug-delivery/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/dna-nanostructures-for-drug-delivery/</link>
          <title>Self-assembling nanocages built from strands of DNA (above) could one day deliver drugs, or house tiny bioreactors or photonic devices; a superresolution microscopy method developed at the Wyss Institute, DNA-PAINT (below) visualizes structures using short strands of DNA (yellow) labeled with a fluorescent chemical (green) to bind and release partner strands on the cages’ corners, causing them to blink. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2016/09/16222604/DNA-origami-polyhedra-featured-image.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=5df8df2a1ef47171a8fe54a970c74603"/></url>
				</image>
        			</item>

		
			<item>
				<title>DNA origami-based vaccines toward safe and highly-effective precision cancer immunotherapy</title>
				<link>https://wyss.stage.a17.io/news/dna-origami-based-vaccines-toward-safe-and-highly-effective-precision-cancer-immunotherapy/</link>
        <pubDate>Fri, 15 Mar 2024 11:00:37 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cancer Vaccine]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[David Mooney]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=39256</guid>
                            <description>Broadly applicable vaccine platform enables enhanced anti-tumor responses through nanometer-precise spacing of adjuvant molecules and a variety of antigens</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Therapeutic cancer vaccines are a form of immunotherapy in the making that could not only destroy cancer cells in patients, but keep a cancer from coming back and spreading. Multiple therapeutic cancer vaccines are being studied in clinical trials, but despite their promise, they are not routinely used yet by clinical oncologists to treat their patients.</p>
<p><a href="https://wyss.stage.a17.io/news/dna-origami-based-vaccines-toward-safe-and-highly-effective-precision-cancer-immunotherapy/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/dna-origami-based-vaccines-toward-safe-and-highly-effective-precision-cancer-immunotherapy/</link>
          <title>Due to their nanoprecise spacing of adjuvant molecules (shown as green ribbons on one face of their squareblock structures), DoriVac vaccines, after being taken up by antigen-presenting immune cells, can more effectively engage the cells’ activation machinery (shown in purple) in intracellular compartments than free and unorganized adjuvant molecules. Credit: Ju Hee/KIST</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/02/22114149/draft-for-cover-image3_white5.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=5d103ea98ff2b4ad70bb36cd3cdf2a97"/></url>
				</image>
        			</item>

		
			<item>
				<title>What is the future of Engineering with Bioengineering Pioneer Donald E Ingber &#8211; Museum of Science</title>
				<link>https://wyss.stage.a17.io/media-post/what-is-the-future-of-engineering-with-bioengineering-pioneer-donald-e-ingber-museum-of-science/</link>
        <pubDate>Mon, 11 Mar 2024 17:32:32 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Bioinspired Engineering]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=39388</guid>
                                                <content:encoded><![CDATA[<p>Is biological inspiration the key to the future of engineering? Bioethicist Insoo Hyun sits down with Donald E. Ingber, Founding Director of the Wyss Institute for Biologically Inspired Engineering and Professor of Bioengineering at Harvard&rsquo;s School of Engineering &amp; Applied Sciences. Together they explore the profound impact of Nature on engineering beyond the realms of cold, hard mathematics.</p>
<p><a href="https://wyss.stage.a17.io/media-post/what-is-the-future-of-engineering-with-bioengineering-pioneer-donald-e-ingber-museum-of-science/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/what-is-the-future-of-engineering-with-bioengineering-pioneer-donald-e-ingber-museum-of-science/</link>
          <title>Founding Director Donald Ingber. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2016/08/05095242/Donald_Ingber_headshot_1500x1000.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=2eb1f5f4d60b7385b81bdd2ae01f2917"/></url>
				</image>
        			</item>

		
			<item>
				<title>Seed-dependent crisscross DNA-origami slats</title>
				<link>https://wyss.stage.a17.io/media-post/seed-dependent-crisscross-dna-origami-slats/</link>
        <pubDate>Wed, 21 Dec 2022 20:30:26 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[DNA-PAINT]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=35178</guid>
                                                <content:encoded><![CDATA[<p>This animation explains how the newly invented crisscross origami method can be used to build functionalized micron&#x2d;scale DNA megastructures composed of many unique DNA origami &ldquo;slats,&rdquo; each with their own complexity and interactive properties. Credit: Wyss Institute at Harvard University&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/seed-dependent-crisscross-dna-origami-slats/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/seed-dependent-crisscross-dna-origami-slats/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/12/21151738/Crisscross-DNA-Origami_Title-slidege.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=77af037090de1ab3393133a334fea2a5"/></url>
				</image>
        			</item>

		
			<item>
				<title>DNA nanostructures grow up to become micron-scale megastructures</title>
				<link>https://wyss.stage.a17.io/news/dna-nanostructures-grow-up-to-become-micron-scale-megastructures/</link>
        <pubDate>Wed, 21 Dec 2022 20:28:54 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[DNA-PAINT]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Peng Yin]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=34954</guid>
                            <description>New DNA nanofabrication approach enables high-yielding assembly of complex multi-origami megastructures, with potential for many biological and non-biological applications</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; DNA nanostructures assembled from shorter DNA sequences as building blocks have long sparked the imagination of bioengineers because their precisely programable size, shape, and functions could open up a plethora of non&#x2d;biological and biological possibilities. If they could be built to be sufficiently large and complex, we could harness them to create highly&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/dna-nanostructures-grow-up-to-become-micron-scale-megastructures/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/dna-nanostructures-grow-up-to-become-micron-scale-megastructures/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/12/14094834/Crisscross-DNA-Origami_Listing-Image.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=3f4e64f8ee3966c67cb1133f5c012b54"/></url>
				</image>
        			</item>

		
			<item>
				<title>Nanotechnology enables visualization of RNA structures at near-atomic resolution</title>
				<link>https://wyss.stage.a17.io/news/nanotechnology-enables-visualization-of-rna-structures-at-near-atomic-resolution/</link>
        <pubDate>Mon, 02 May 2022 14:56:49 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Peng Yin]]></category>
		<category><![CDATA[RNA]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=32372</guid>
                            <description>Combination of nucleic acid nanotechnology and cryo-EM gives unprecedented insights into the structures of large and small RNAs, enabling fundamental advances in RNA biology and drug design</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; We live in a world made and run by RNA, the equally important sibling of the genetic molecule DNA. In fact, evolutionary biologists hypothesize that RNA existed and self&#x2d;replicated even before the appearance of DNA. Fast forward to modern day humans: science has revealed that less than 3% of the human genome is transcribed into messenger RNA (mRNA) molecules&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/nanotechnology-enables-visualization-of-rna-structures-at-near-atomic-resolution/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/nanotechnology-enables-visualization-of-rna-structures-at-near-atomic-resolution/</link>
          <title>This illustration is inspired by the Paleolithic rock painting in the Lascaux cave, signifying the acronym of our method, ROCK. Figuratively, the patterns of the rock art in the background (brown) are the 2D projections of the engineered dimeric construct of the Tetrahymena group I intron, while the main object in the front (blue) is the reconstructed 3D cryo-EM map of the dimer, with one monomer in focus and refined to the high resolution that allowed the collaborators to build an atomic model of the RNA. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/04/29171705/ROCK-Cover.png?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=06df98dc2e823ba46a7b3a5d50a8a5ed"/></url>
				</image>
        			</item>

		
			<item>
				<title>Turning Science Fiction into Science Reality with Crisscross Nanotechnology</title>
				<link>https://wyss.stage.a17.io/news/turning-science-fiction-into-science-reality-with-crisscross-nanotechnology/</link>
        <pubDate>Mon, 01 Nov 2021 20:09:39 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=30549</guid>
                            <description>Using DNA to build a physical platform that transforms molecular diagnostics</description>
                                        <content:encoded><![CDATA[<p>Despite the current widespread availability of tests that can diagnose COVID&#x2d;19, diagnostics is an industry that is ripe for improvement: diagnostic errors and other inefficiencies cost the U.S. economy $750 billion each year, even without a pandemic to deal with. The Wyss Institute&rsquo;s Crisscross Nanoseed Detection is an enzyme&#x2d;free DNA nanotechnology that can be used for rapid, ultrasensitive&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/turning-science-fiction-into-science-reality-with-crisscross-nanotechnology/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/turning-science-fiction-into-science-reality-with-crisscross-nanotechnology/</link>
          <title>Caption: Dionis Minev (left) and Anastasia Ershova (right) are developing the Crisscross Nanoseed Detection technology at the Wyss Institute. Credit: Wyss Institute.</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2021/11/02134355/Anastasia-and-Dionis-Crisscross-Start-up-0268.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=86afe6603f0e438c62c7bb59afd13162"/></url>
				</image>
        			</item>

		
			<item>
				<title>DNA: From blueprint to blank slate</title>
				<link>https://wyss.stage.a17.io/news/dna-from-blueprint-to-blank-slate/</link>
        <pubDate>Fri, 23 Apr 2021 14:03:24 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[David R. Walt]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[DNA Bricks]]></category>
		<category><![CDATA[DNA Data Storage]]></category>
		<category><![CDATA[DNA Nanoswitches]]></category>
		<category><![CDATA[DNA sequencing]]></category>
		<category><![CDATA[DNA synthesis]]></category>
		<category><![CDATA[DNA writing]]></category>
		<category><![CDATA[DNA-PAINT]]></category>
		<category><![CDATA[Gene Sequencing]]></category>
		<category><![CDATA[Genome]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Pamela Silver]]></category>
		<category><![CDATA[Peng Yin]]></category>
		<category><![CDATA[Wesley Wong]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=28219</guid>
                            <description>In the half-century since its structure was identified, DNA has become one of the most powerful and versatile tools in biotechnology</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell DNA has come a long way since it was first described in 1869 by Swiss chemist Friedrich Miescher. So much so, in fact, that in 2003 the US Congress designated April 25th National DNA Day to commemorate the successful completion of the Human Genome Project that year, and the discovery of DNA&rsquo;s double helix structure in 1953. Since then, DNA has become an incredibly valuable&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/dna-from-blueprint-to-blank-slate/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/dna-from-blueprint-to-blank-slate/</link>
          <title>Sequencing molecules of DNA to determine the order of As, Gs, Cs, and Ts along their length was time-consuming and expensive when the Human Genome Project began in 1984. Now, thanks to innovations created by Wyss Core Faculty members George Church and David Walt, it's cheap and commonplace. Credit: Shutterstock</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2021/04/21165818/DNA-Sequence_shutterstock_218141077.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c7234639f9fb1320290927947f771734"/></url>
				</image>
        			</item>

			</channel>
</rss>
